Research indicates the peptide crosses the blood-brain barrier, potentially offering neuroprotective benefits (Sikiric et al., Current Pharmaceutical Design, 2020)
While mild mood changes are common, persistent or severe emotional symptoms should be discussed with a healthcare professional
It is not approved for human consumption or therapeutic use
DreamWell, research compound, third party tested, COA available, Disguised Alpha, Aerosol Research Products exclusive DreamWell is commonly positioned around multi-compound pathway research, formulation comparison, synergistic research models
Compounded Drug Distinction: ProHealth sells BPC-157 as a dietary supplement regulated under DSHEA - not as a compounded prescription medication
Rat wound healing studies using GHK showed 64.5% reduction in wound size compared to 45.6% for vehicle-treated and 28.2% for control groups